Decoy Biosystems Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $30M

Decoy Biosystems General Information

Description

Developer of novel anti-cancer and anti-viral immunotherapy designed to eliminate viral and bacterial infections. The company's immunotherapy eradicates existing tumors with the induction of immunological memory in standard pre-clinical models and is also active against established human hepatitis b and HIV infection in standard pre-clinical models, enabling researchers to modify and kill non-pathogenic bacteria utilized in biotherapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • 3210 Merryfield Row
  • JLABS
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Decoy Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 03-Aug-2021 $30M 00.000 0000 Completed Generating Revenue
4. Later Stage VC 03-May-2021 00.000 00.000 Completed Pre-Clinical Trials
3. Seed Round 01-Oct-2018 00.000 00.000 0000 Completed Pre-Clinical Trials
2. Accelerator/Incubator 06-Aug-2018 $1.5M Completed Pre-Clinical Trials
1. Angel (individual) $1.5M $1.5M Completed Startup
To view Decoy Biosystems’s complete valuation and funding history, request access »

Decoy Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 000,000 00.000000 000.00 000.00 00 000.00 00.000
To view Decoy Biosystems’s complete cap table history, request access »

Decoy Biosystems Patents

Decoy Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2759854-T3 Compositions and methods for cancer treatment using bacteria Active 02-Jan-2013 000000000
EP-2941258-B1 Compositions and methods for treatment of cancer using bacteria Active 02-Jan-2013 000000000
AU-2013371454-B2 Compositions and methods for treatment of cancer using bacteria Active 02-Jan-2013 000000000
JP-2016505604-A Composition for treating cancer using bacteria and use of bacteria for its production Active 02-Jan-2013 000000000 0
JP-6125041-B2 Composition for treating cancer using bacteria and use of bacteria for its production Active 02-Jan-2013 A61K35/74
To view Decoy Biosystems’s complete patent history, request access »

Decoy Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Decoy Biosystems Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority 000 0000 000000 0
Mountain Pacific Venture Partners Venture Capital Minority 000 0000 000000 0
Savantus Ventures Venture Capital Minority 000 0000 000000 0
TY BIO Investment Venture Capital Minority 000 0000 000000 0
To view Decoy Biosystems’s complete investors history, request access »